VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16.27	30.62	30.91	42.25	57.56	43.76
Short-Term Investments	53.91	62.63	-	-	1.03	28.35
Cash & Short-Term Investments	70.19	93.25	30.91	42.25	58.59	72.11
Cash Growth	354.33%	201.71%	-26.84%	-27.89%	-18.75%	-26.86%
Accounts Receivable	-	-	-	7.58	15.82	0.14
Other Receivables	-	-	5	-	-	-
Receivables	-	-	5	7.58	15.82	0.14
Inventory	-	-	-	-	7.4	1.36
Prepaid Expenses	3.3	2.66	2.3	4.57	4.59	1.56
Restricted Cash	0.05	0.05	0.07	0.61	0.86	0.83
Other Current Assets	-	-	-	8.18	-	0.43
Total Current Assets	73.54	95.96	38.28	63.19	87.26	76.41
Property, Plant & Equipment	0.12	0.21	-	0.35	2.14	4.58
Other Long-Term Assets	2.54	1.52	2.48	3.51	4.35	0.17
Total Assets	76.2	97.69	40.76	67.05	93.74	81.16
Accounts Payable	3.99	1.66	2.39	6.51	4.78	19.35
Accrued Expenses	7.24	3.51	4.26	6.06	10.32	8.61
Current Portion of Leases	0.12	0.12	-	0.35	0.76	1.09
Current Unearned Revenue	-	-	-	-	5.8	-
Other Current Liabilities	1.31	2.25	2.7	5.49	0.1	0.27
Total Current Liabilities	12.66	7.54	9.35	18.41	21.77	29.33
Long-Term Debt	-	-	-	-	33.17	32.73
Long-Term Leases	-	0.1	-	-	0.85	0.65
Other Long-Term Liabilities	-	1.31	-	-	0.46	0.46
Total Liabilities	12.66	8.95	9.35	18.41	56.25	63.58
Common Stock	0	0	-	0.01	0	0
Additional Paid-In Capital	782.65	780.04	693.94	688.16	603.69	328.16
Retained Earnings	-719.15	-691.34	-662.74	-639.53	-566.2	-310.59
Comprehensive Income & Other	0.03	0.03	-	-	-	0.01
Total Common Equity	63.54	88.74	31.2	48.64	37.49	17.58
Shareholders' Equity	63.54	88.74	31.41	48.64	37.49	17.58
Total Liabilities & Equity	76.2	97.69	40.76	67.05	93.74	81.16
Total Debt	0.12	0.21	-	0.35	34.78	34.47
Net Cash (Debt)	70.06	93.04	30.91	41.9	23.81	37.64
Net Cash Growth	353.53%	201.02%	-26.24%	76.01%	-36.75%	-61.88%
Net Cash Per Share	1.76	9.06	9.70	14.66	13.22	79.84
Filing Date Shares Outstanding	14.75	14.1	3.26	3.12	2.85	61.63
Total Common Shares Outstanding	14.75	14.1	3.23	2.98	2.4	61.58
Working Capital	60.87	88.43	28.93	44.78	65.49	47.09
Book Value Per Share	4.31	6.29	9.66	16.34	15.62	0.29
Tangible Book Value	63.54	88.74	31.2	48.64	37.49	17.58
Tangible Book Value Per Share	4.31	6.29	9.66	16.34	15.62	0.29
Machinery	-	-	-	0.85	0.94	3.07
Leasehold Improvements	-	-	-	0.06	0.06	1.05

Source: S&P Capital IQ. Standard template. Financial Sources.